Table 6.
Newborns’ characteristics and maternal–foetal complications.
| Rheumatic Diseases | Thrombophilias | |||||
|---|---|---|---|---|---|---|
| SLE (n = 70) |
Primary APS (n = 56) |
Other RD (n = 20) |
RA (n = 6) |
Primary HT (n = 39) |
p Value | |
| Pregnancy (mean; SD) | ||||||
| Gestation (weeks) | 36.1 (7.9) | 37.4 (5.4) | 37.5 (1.5) | 39 (8.7) | 36.9 (8.6) | 0.001 * |
| Newborn weight (grams) | 2873.9 (643.4) | 3023.5 (569.2) | 3126.8 (529.3) | 2860 (508.2) | 3246.4 (454.3) | 0.013 ** |
| Type of delivery, frequency (%) | ||||||
| Eutocic delivery | 33 (47.1) | 30 (53.6) | 12 (60) | 4 (66.7) | 19 (48.7) | 0.967 |
| Caesarean section | 25 (35.7) | 20 (35.7) | 6 (30) | 2 (33.3) | 15 (38.5) | |
| Instrumental delivery | 12 (17.1) | 6 (10.7) | 2 (10) | 0 (0) | 5 (12.8) | |
| Maternal pathology, not eutocic | 4 (5.7) | 2 (3.6) | 1 (5) | 0 (0) | 0 (0) | 0.605 |
| Foetal complications, frequency (%) | ||||||
| IUGR | 3 (4.3) | 6 (10.7) | 0 (0) | 0 (0) | 1 (2.6) | 0.376 |
| Prematurity | 12 (17.1) | 9 (16.1) | 1 (5) | 0 (0) | 0 (0) | 0.023 |
| CHB | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | - |
| No foetal complications | 56 (80) | 43 (76.8) | 19 (95) | 6 (100) | 38 (97.4) | 0.021 |
| Maternal complications, frequency (%) | ||||||
| Preeclampsia | 7 (10) | 3 (5.4) | 0 (0) | 0 (0) | 0 (0) | 0.191 |
| Postpartum DVT | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (2.6) | 0.376 |
| No maternal complications | 61 (87.1) | 53 (94.4) | 20 (100) | 6 (100) | 38 (97.4) | 0.213 |
(Kruskal–Wallis test, Fisher’s exact test, and Pearson’s Chi-Squared test). Systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS), hereditary thrombophilias (HT), rheumatic diseases (RD), rheumatoid arthritis (RA), standard deviation (SD), intrauterine growth retardation (IUGR), congenital heart block (CHB), and deep vein thrombosis (DVT).